Oligomannosides and the HIV Antibody

  • Author: ChemViews
  • Published Date: 08 January 2011
  • Source / Publisher: Chemistry - A European Journal/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
thumbnail image: Oligomannosides and the HIV Antibody

Related Societies

A vaccine for the HIV virus still eludes us, but the vaccine-development strategy, retrovaccinology, i.e., going from the antibody to the vaccine, could identify new synthetic targets. To that aim, the human monoclonal antibody, 2G12, has been isolated from some infected individuals and has demonstrated a broad neutralization profile.

Jesús Angulo and colleagues, Instituto de Investigaciones Químicas, Spain, have investigated the interactions of five synthetic linear di-, tri-, and tetraoligomannosides and branched penta- and heptaoligomannosides in solution with 2G12.

By using saturation transfer difference NMR spectroscopy and transferred NOE experiments, they showed linear oligomannosides have a single binding mode, while the branched pentamannosides have two alternate binding modes, contrary to previous X-ray studies.

This data will impact the design of multivalent, high-mannose glycoconjugate mimics for vaccines.

Article Views: 3106

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH